on O3 Holding GmbH (isin : NO0013360552)
O3 Holding GmbH Releases Q1 2026 Interim Report
O3 Holding GmbH, based in Bioggio, Switzerland, has released its Q1 2026 interim financial report. As the parent company of KD Pharma Group, O3 Holding GmbH is involved in the production of pharmaceutical and nutritional lipids. This release fulfills obligations linked to its floating rate note (FRN) senior secured bond, valued at 180 million euros, with the ISIN NO0013360552, issued in October 2024.
The full report is accessible on the company's official website. The document's publication aligns with regulatory requirements for maintaining transparency with stakeholders and investors. The company's stock is listed on the regulated unofficial market in Frankfurt, offering further details on its financial health and business operations.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all O3 Holding GmbH news